Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apatinib Combined With Oxaliplatin and Gimeracil and Oteracil Porassium Capsules Neoadjuvant Therapy for Locally Advanced Gastric Cance: A Multicentre, One-armed, Clinical Pilot Trial

NCT03192735 is registered in ClinicalTrials.gov with Chang-Ming Huang, Prof. as lead sponsor.

NCT NCT03192735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03192735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apatinib Combined With Oxaliplatin and Gimeracil and Oteracil Porassium Capsules Neoadjuvant Therapy for Locally Advanced Gastric Cance: A Multicentre, One-armed, Clinical Pilot Trial
Lead sponsor
Chang-Ming Huang, Prof.
Phase
Phase 2
Overall status
Unknown status
Start date
September 1, 2017
Completion date
December 11, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apatinib combined, locally advanced gastric cancer, neoadjuvant therapy, sox